Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials
12 mai 2014 09h15 HE
|
Rafarma Pharmaceuticals, Inc.
MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to...
Rafarma (RAFA) Enters $50,000,000 Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
06 juin 2013 09h18 HE
|
Rafarma Pharmaceuticals, Inc.
SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone.
Ceftriaxone treats...
Four EndoHeroes(TM) Honored for Contributions
27 mars 2013 07h00 HE
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Mar 27, 2013) - In recognition of GI Nurses Day and the many GI professionals who dedicate themselves to patient care, EndoChoice, Inc. is honoring four GI...
EndoChoice Awarded GI Contract With the Premier Healthcare Alliance
22 janv. 2013 11h15 HE
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Jan 22, 2013) - EndoChoice, Inc. announced today that it has been awarded a group purchasing agreement with the Premier Healthcare Alliance for its gastrointestinal...
EndoChoice Recognized as One of Georgia's Top Job Creators
07 déc. 2012 07h18 HE
|
EndoChoice
ALPHARETTA, GA--(Marketwire - Dec 7, 2012) - EndoChoice, Inc., a platform technology company focused on gastrointestinal (GI) endoscopy, is featured in the inaugural ranking of Inc. Magazine's...
Tranzyme Pharma Announces Third Quarter 2012 Financial Results
08 nov. 2012 16h30 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class...
Tranzyme Pharma to Host Third Quarter 2012 Financial Results Conference Call on Friday, November 9, 2012
25 oct. 2012 05h10 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will host a conference call on Friday, November 9, 2012 at 8:30 am ET to discuss...
Tranzyme Pharma to Present at BIO Investor Forum on October 10, 2012
03 oct. 2012 13h30 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will present at the 11th Annual BIO Investor...
Tranzyme Pharma Announces Exercise of Underwriters' Over-Allotment Option and Closing of $11.5 Million Registered Direct Offering of Common Stock
18 sept. 2012 16h30 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that it has closed the previously announced underwritten registered direct offering of...
Tranzyme Pharma Raises $10 Million in Registered Direct Offering
13 sept. 2012 05h10 HE
|
Ocera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it has agreed to sell approximately 2.6 million shares of its common stock at a...